Stephan Röver
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Cannabis and Cannabinoid Research, Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Neurotransmitter Receptor Influence on Behavior, Tryptophan and brain disorders
Most-Cited Works
- → Synthesis and Biochemical Evaluation ofN-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase(1997)208 cited
- → NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS(2018)163 cited
- → High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor(2000)82 cited
- → Synthesis and applications of fluorous silyl protecting groups with improved acid stability(1999)68 cited
- → 8-Acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists(1999)62 cited
- → Novel Triazolopyrimidine‐Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases(2015)56 cited
- → Singlet Oxygen Quenching Abilities of Carotenoids(1997)56 cited
- → Cloning and functional expression of human kynurenine 3‐monooxygenase(1997)43 cited
- → Benzodioxoles: Novel Cannabinoid-1 Receptor Inverse Agonists for the Treatment of Obesity(2008)42 cited
- → 6-Alkoxy-5-aryl-3-pyridinecarboxamides, a New Series of Bioavailable Cannabinoid Receptor Type 1 (CB1) Antagonists Including Peripherally Selective Compounds(2013)34 cited